Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

61

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Role of plasmin in metastatic tumors

Related Posts

The temporal dynamics of the gut mycobiome and its association with cardiometabolic health in a nationwide cohort of 12,641 Chinese adults

The temporal dynamics of the gut mycobiome and its asso...

73

Circulating miR-126-3p is a mechanistic biomarker for knee osteoarthritis

Circulating miR-126-3p is a mechanistic biomarker for k...

73

Neuropeptide therapeutics to repress lateral septum neurons that disable sociability in an autism mouse model

Neuropeptide therapeutics to repress lateral septum neu...

75